Emerging lawsuits are focusing on whether manufacturers adequately warned patients and healthcare providers about the risk of serious vision complications
How Do You Design a Symptom Diary That Points to Solutions
The 0.25 mg dose is intended for treatment initiation and is not effective for glycemic control
Interactions with other diabetes medications: To avoid potential interactions, close monitoring is advised when using tirzepatide alongside other diabetes medications, such as sulfonylureas, SGLT-2 inhibitors, metformin, or insulin
If youre tolerating the medication well and seeing results, there may be room for dosage escalation to enhance the benefits or manage side effects
Healthcare providers should maintain detailed records of patient medications, laboratory results, and treatment responses to facilitate early recognition of drug interactions and appropriate intervention when complications develop